Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 23, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
The filing details a specific change in share ownership:
- Director: Mr. R Bondy
- Transaction Type: Transfer by gift
- Quantity: 3,540 Ordinary shares
- Transaction Date: March 21, 2006
- Notification Date: March 22, 2006
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transaction noted above.
Investor Verification Points
- Verify the total shareholding of Mr. R Bondy following the gift of 3,540 shares.
- Confirm the classification of the transaction under Disclosure Rule 3.1.4R(1)(a).
- Note that this filing does not reflect the company's operational or financial status for the period.